As of 1st May 2019 Inotuzumab (Besponsa) will be available on the PBS for patients with relapsed acute lymphocytic leukaemia (ALL) or refractory CD22 positive B-cell precursor ALL. The treatment costs $120,000 per course but
Chimeric Antigen Receptor T-cell (CAR T-cell) therapies are providing Australian blood cancer patients with real hope. From the Federal Government announcing an investment in the Peter MacCallum Cancer Centre to support CAR T-cell treatment to
“You have the opportunity to help one patient in front of you when you are a clinician, but when working in the laboratory you have the opportunity to help millions of patients when you make
Tom Long so generously told of his battle with myeloma to Lisa Wilkinson on The Project to raise awareness for Snowdome. Tom wanted to ensure that funds were raised for blood cancer research to help
Patrick Devine is a long time supporter of Snowdome. He was diagnosed with a rare blood cancer 10 years ago and is defying the usual life expectancy of his cancer type with the help of
The FireFlies Antipodes suffered on their bikes for 800kms in order to raise funds for blood cancer research. Snowdome co-Founder Grant Rutherford joined the FireFlies, here is his story. For those who suffered, I drove.
The Snowdome Foundation has partnered with Dr Eliza Hawkes, from the Olivia Newton John Cancer Centre at the Austin hospital in Melbourne who has established the Australasian Lymphoma Alliance (ALA). The premise of the ALA